Matthew C. Radey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matthew C. Radey has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin D. Ross
Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College
2 shared publications - Elhanan Borenstein
Tel Aviv University
2 shared publications - Joseph D. Mougous
Department of Microbiology, University of Washington
2 shared publications Adeline M. Hajjar
University of Washington
1 shared publication- Adrian J. Verster
University of Washington
1 shared publication - Adrian J. Verster
University of Washington
1 shared publication
Latest Publications
- Open Access
- 22 December 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (24)
A population-level strain genotyping method to study pathogen strain dynamics in human infections
A hallmark of chronic bacterial infections is the long-term persistence of 1 or more pathogen species at the compromised site. Repeated detection of the same bacterial species can suggest that a single strain or lineage is continually present. However, infection with multiple strains of a given species, strain acquisition and loss, and changes in strain relative abundance can occur. Detecting strain-level changes and their effects on disease is challenging because most methods require labor-intensive isolate-by-isolate analyses, and thus, only a few cells from large infecting populations can be examined. Here, we present a population-level method for enumerating and measuring the relative abundance of strains called population multi-locus sequence typing (PopMLST). The method exploits PCR amplification of strain-identifying polymorphic loci, next-generation sequencing to measure allelic variants, and informatic methods to determine whether variants arise from sequencing errors or low-abundance strains. These features enable PopMLST to simultaneously interrogate hundreds of bacterial cells that are cultured en masse from patient samples or are present in DNA directly extracted from clinical specimens without ex vivo culture. This method could be used to detect epidemic or super-infecting strains, facilitate understanding of strain dynamics during chronic infections, and enable studies that link strain changes to clinical outcomes.
- 22 December 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (24)
Open AccessA population-level strain genotyping method to study pathogen strain dynamics in human infections
A hallmark of chronic bacterial infections is the long-term persistence of 1 or more pathogen species at the compromised site. Repeated detection of the same bacterial species can suggest that a single strain or lineage is continually present. However, infection with multiple strains of a given species, strain acquisition and loss, and changes in strain relative abundance can occur. Detecting strain-level changes and their effects on disease is challenging because most methods require labor-intensive isolate-by-isolate analyses, and thus, only a few cells from large infecting populations can be examined. Here, we present a population-level method for enumerating and measuring the relative abundance of strains called population multi-locus sequence typing (PopMLST). The method exploits PCR amplification of strain-identifying polymorphic loci, next-generation sequencing to measure allelic variants, and informatic methods to determine whether variants arise from sequencing errors or low-abundance strains. These features enable PopMLST to simultaneously interrogate hundreds of bacterial cells that are cultured en masse from patient samples or are present in DNA directly extracted from clinical specimens without ex vivo culture. This method could be used to detect epidemic or super-infecting strains, facilitate understanding of strain dynamics during chronic infections, and enable studies that link strain changes to clinical outcomes.
- Open Access
Acquired interbacterial defense systems protect against interspecies antagonism in the human gut microbiome
The impact of direct interactions between co-resident microbes on microbiome composition is not well understood. Here we report the occurrence of acquired interbacterial defense (AID) gene clusters in bacterial residents of the human gut microbiome. These clusters encode arrays of immunity genes that protect against type VI secretion toxin-mediated intra- and inter-species bacterial antagonism. Moreover, the clusters reside on mobile elements and we demonstrate that their transfer is sufficient to confer toxin resistance in vitro and in gnotobiotic mice. Finally, we identify and validate the protective capacity of a recombinase-associated AID subtype ( r AID-1) present broadly in Bacteroidales genomes. These r AID-1 gene clusters have a structure suggestive of active gene acquisition and include predicted immunity factors of toxins deriving from diverse organisms. Our data suggest that neutralization of contact-dependent interbacterial antagonism via AID systems shapes human gut microbiome ecology.
Open AccessAcquired interbacterial defense systems protect against interspecies antagonism in the human gut microbiome
The impact of direct interactions between co-resident microbes on microbiome composition is not well understood. Here we report the occurrence of acquired interbacterial defense (AID) gene clusters in bacterial residents of the human gut microbiome. These clusters encode arrays of immunity genes that protect against type VI secretion toxin-mediated intra- and inter-species bacterial antagonism. Moreover, the clusters reside on mobile elements and we demonstrate that their transfer is sufficient to confer toxin resistance in vitro and in gnotobiotic mice. Finally, we identify and validate the protective capacity of a recombinase-associated AID subtype ( r AID-1) present broadly in Bacteroidales genomes. These r AID-1 gene clusters have a structure suggestive of active gene acquisition and include predicted immunity factors of toxins deriving from diverse organisms. Our data suggest that neutralization of contact-dependent interbacterial antagonism via AID systems shapes human gut microbiome ecology.
- Open Access
The Landscape of Type VI Secretion across Human Gut Microbiomes Reveals its Role in Community Composition
While the composition of the human gut microbiome has been well defined, the forces governing its assembly are poorly understood. Recently, prominent members of this community from the order Bacteroidales were shown to possess the type VI secretion system (T6SS), which mediates contact-dependent antagonism between Gram-negative bacteria. However, the distribution of the T6SS in human gut microbiomes and its role have not yet been characterized. To address this challenge, we construct an extensive catalog of T6SS effector/immunity (E-I) genes from three genetic architectures (GA1-3) found in Bacteroidales genomes. We then use metagenomic analysis to assess the abundances of these genes across a large set of gut microbiome samples. We find that despite E–I diversity across reference strains, each individual microbiome harbors a limited set of E-I genes representing a single E–I genotype. Importantly, for GA1-2, these genotypes are not associated with a specific species, suggesting selection for compatibility. GA3, in contrast, is restricted to B. fragilis , and its low diversity reflects a single B. fragilis strain per sample. We further show that in infant microbiomes GA3 is enriched and B. fragilis strains are replaced over time, suggesting competition for dominance in developing microbiomes. Finally, we find a strong association between the presence of GA3 and increased abundance of Bacteroides, indicating that this system confers a selective advantage in vivo in Bacteroides rich ecosystems. Combined, our findings provide the first comprehensive characterization of the T6SS landscape in the human microbiome, implicating it in both intra- and inter-species interactions.
Open AccessThe Landscape of Type VI Secretion across Human Gut Microbiomes Reveals its Role in Community Composition
While the composition of the human gut microbiome has been well defined, the forces governing its assembly are poorly understood. Recently, prominent members of this community from the order Bacteroidales were shown to possess the type VI secretion system (T6SS), which mediates contact-dependent antagonism between Gram-negative bacteria. However, the distribution of the T6SS in human gut microbiomes and its role have not yet been characterized. To address this challenge, we construct an extensive catalog of T6SS effector/immunity (E-I) genes from three genetic architectures (GA1-3) found in Bacteroidales genomes. We then use metagenomic analysis to assess the abundances of these genes across a large set of gut microbiome samples. We find that despite E–I diversity across reference strains, each individual microbiome harbors a limited set of E-I genes representing a single E–I genotype. Importantly, for GA1-2, these genotypes are not associated with a specific species, suggesting selection for compatibility. GA3, in contrast, is restricted to B. fragilis , and its low diversity reflects a single B. fragilis strain per sample. We further show that in infant microbiomes GA3 is enriched and B. fragilis strains are replaced over time, suggesting competition for dominance in developing microbiomes. Finally, we find a strong association between the presence of GA3 and increased abundance of Bacteroides, indicating that this system confers a selective advantage in vivo in Bacteroides rich ecosystems. Combined, our findings provide the first comprehensive characterization of the T6SS landscape in the human microbiome, implicating it in both intra- and inter-species interactions.
- Open Access
- 1 January 2014
- Published by Springer Nature in BMC Genomics
- Vol. 15 (1) , 1-14
Genomic analysis of the emergence of 20th century epidemic dysentery
Shigella dysenteriae type 1 (Sd1) causes recurrent epidemics of dysentery associated with high mortality in many regions of the world. Sd1 infects humans at very low infectious doses (10 CFU), and treatment is complicated by the rapid emergence of antibiotic resistant Sd1 strains. Sd1 is only detected in the context of human infections, and the circumstances under which epidemics emerge and regress remain unknown. Phylogenomic analyses of 56 isolates collected worldwide over the past 60 years indicate that the Sd1 clone responsible for the recent pandemics emerged at the turn of the 20th century, and that the two world wars likely played a pivotal role for its dissemination. Several lineages remain ubiquitous and their phylogeny indicates several recent intercontinental transfers. Our comparative genomics analysis reveals that isolates responsible for separate outbreaks, though closely related to one another, have independently accumulated antibiotic resistance genes, suggesting that there is little or no selection to retain these genes in-between outbreaks. The genomes appear to be subjected to genetic drift that affects a number of functions currently used by diagnostic tools to identify Sd1, which could lead to the potential failure of such tools. Taken together, the Sd1 population structure and pattern of evolution suggest a recent emergence and a possible human carrier state that could play an important role in the epidemic pattern of infections of this human-specific pathogen. This analysis highlights the important role of whole-genome sequencing in studying pathogens for which epidemiological or laboratory investigations are particularly challenging.
- 1 January 2014
- Published by Springer Nature in BMC Genomics
- Vol. 15 (1) , 1-14
Open AccessGenomic analysis of the emergence of 20th century epidemic dysentery
Shigella dysenteriae type 1 (Sd1) causes recurrent epidemics of dysentery associated with high mortality in many regions of the world. Sd1 infects humans at very low infectious doses (10 CFU), and treatment is complicated by the rapid emergence of antibiotic resistant Sd1 strains. Sd1 is only detected in the context of human infections, and the circumstances under which epidemics emerge and regress remain unknown. Phylogenomic analyses of 56 isolates collected worldwide over the past 60 years indicate that the Sd1 clone responsible for the recent pandemics emerged at the turn of the 20th century, and that the two world wars likely played a pivotal role for its dissemination. Several lineages remain ubiquitous and their phylogeny indicates several recent intercontinental transfers. Our comparative genomics analysis reveals that isolates responsible for separate outbreaks, though closely related to one another, have independently accumulated antibiotic resistance genes, suggesting that there is little or no selection to retain these genes in-between outbreaks. The genomes appear to be subjected to genetic drift that affects a number of functions currently used by diagnostic tools to identify Sd1, which could lead to the potential failure of such tools. Taken together, the Sd1 population structure and pattern of evolution suggest a recent emergence and a possible human carrier state that could play an important role in the epidemic pattern of infections of this human-specific pathogen. This analysis highlights the important role of whole-genome sequencing in studying pathogens for which epidemiological or laboratory investigations are particularly challenging.